AA Contact info

Patricia Gibson
Phone: 919.838.2093
Fax: 919.821.6800
pgibson@smithlaw.com

Practice Areas

Bar & Court Admissions

  • North Carolina
  • Massachusetts

Education

UC Berkeley School of Law, J.D., 2001

  • Order of the Coif

Harvard College, A.B. in biochemical sciences, magna cum laude, 1998

Clerkships

  • Clerked for Chief Justice Margaret H. Marshall of the Massachusetts Supreme Judicial Court, 2001-2002
Find Professionals
Photo of John R. Therien

John R. Therien

Partner
  • 150 Fayetteville Street, Suite 2300
    Raleigh, North Carolina 27601
  • Phone: 919.821.6614
  • Fax: 919.821.6800

John Therien advises a broad range of clients in commercial transactions involving intellectual property, including domestic and international corporate partnering, patent and technology licensing, research and development collaborations, joint ventures, mergers and acquisitions, supply chain, distribution, and co-promotion arrangements, and other strategic commercial transactions.  He has extensive experience advising companies in the agricultural biotechnology and pharmaceutical industries and also frequently counsels clients in the diagnostics, medical device, software, video game, and technology sectors on transactional matters. Prior to joining Smith Anderson, John practiced at Ropes & Gray LLP in Boston.

Professional & Community Affiliations

  • Licensing Executives Society
  • North Carolina Bar Association
  • Wake County Bar Association
  • American Bar Association
  • Member, Research Committee, Chordoma Foundation

Honors & Awards

  • Chambers USA: America’s Leading Business Lawyers, Intellectual Property (2016)
  • North Carolina Super Lawyers, Rising Star (2010-2016)
  • Triangle Business Journal's 2016 "40 Under 40" Leadership Award
  • Berkeley Technology Law Journal, Associate Editor
  • Certificate in Law and Technology, UC Berkeley School of Law
  • Thelen, Marrin Prize for Law Journal Writing
  • Order of the Coif, UC Berkeley School of Law
  • Phi Beta Kappa, Harvard College

Experience

  • Lead counsel to a venture capital-funded genome editing company in a worldwide partnership, worth up to $1.6 billion, including an upfront payment of $105 million, with a global, publicly-traded pharmaceutical company to develop and commercialize allogeneic chimeric antigen receptor (CAR) T cell therapies for multiple cancers. The transaction was awarded the 2016 Life Science sector Deals of Distinction™ award by the Licensing Executives Society.
  • Represented a venture capital-funded biotechnology company that uses the plant-associated microbiome to create innovative agricultural products in an R&D collaboration with a leading global agricultural biotechnology company for discovery, development and commercialization of crop trait products
  • Advised a biotechnology company focused on discovery of complex traits for improving intrinsic yield in plants in multiple research collaborations and commercial partnerships with agricultural biotechnology companies in the U.S., France and Brazil
  • Counsel to U.S. and international biotechnology companies in R&D collaborations related to plant genome editing technologies with five of the “Big Six” largest international agricultural biotechnology companies
  • Represented a private equity fund in its newly-formed portfolio company's acquisition and in-license of rights to a commercial-stage biologic drug product from a Fortune 500 pharmaceutical company
  • Counsel to a specialty pharmaceutical company in an exclusive out-license of clinical stage pharmaceutical products for treatment of metabolic disease to a leading international pharmaceutical company in Latin America
  • Advised a publicly-traded specialty pharmaceutical company in multiple exclusive in-licenses of Phase 3 clinical pharmaceutical assets from German, Spanish and U.S. pharmaceutical companies
  • Counsel to a plant-made pharmaceutical company in its exclusive collaboration with an international animal health company for the development of vaccine products
  • Represented university spin-outs in licensing foundational technology from universities such as Harvard University/Massachusetts General Hospital, Columbia University, Duke University, Johns Hopkins University, University of California at San Francisco, Duquesne University, University of North Carolina at Chapel Hill, North Carolina State University, University of Pennsylvania, University of Virginia and Virginia Tech
  • Counsel to a university licensee in its exclusive out-license of pre-clinical pharmaceutical assets to a publicly-traded European pharmaceutical company
  • Advised a leading video game company in the sale of a game franchise to a global computer software company and in the development of an innovative licensing model for the client's video game development software
  • Counsel to a global solid state LED lighting and semiconductor manufacturing company in technology research and development and licensing transaction

News

Events

  • Moderator, AgBio Workshop: Navigating the Big Six, CED Life Sciences Conference, March 2, 2016
  • Presenter, Protecting the Business and Your Intellectual Property, CED FastTrac TechVenture Program, November 17, 2011